Remove keyword drug-candidates
article thumbnail

AI in pharma: Can it be used in DTC?

World of DTC Marketing

Drug Discovery and Manufacturing: It helps in the initial screening of drug compounds to the predicted success rate based on biological factors. Precision medicine or next-generation sequencing helps in the faster discovery of drugs and tailored medication for individual patients. . Measuring RNA, DNA quickly.

Doctors 164
article thumbnail

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

NAMPT inhibitors are a class of drugs that target the enzyme nicotinamide phosphoribosyltransferase (NAMPT). One of the main challenges is the development of drug resistance, as cancer cells can develop mechanisms to bypass the inhibition of NAMPT. Several trials focused on evaluation of such drugs were discontinued in the past.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)

Rethinking Clinical Trials

The COlchicine Hypertension Trial (COHERENT) is a pragmatic Phase II trial that looked at only hypertension by using registry data to identify patients that receive at least two hypertension drugs. You can always use the system to identify potential candidates and then guide them to the local cardiology, kidney department. Key Points.

Trials 130
article thumbnail

A New, Automated Approach to Patient Identification for Clinical Trials

ACRP blog

Keyword searches, manual reviews, outdated reports, and other time-consuming and expensive methods are commonly used to find eligible candidates for enrollment. By empowering researchers to screen more qualified candidates, VigiLanz speeds up the clinical study process. Tufts Center for the Study of Drug Development.